Surgalign Holdings, Inc. (SRGA): Price and Financial Metrics
GET POWR RATINGS... FREE!
SRGA POWR Grades
- Value is the dimension where SRGA ranks best; there it ranks ahead of 75.87% of US stocks.
- SRGA's strongest trending metric is Growth; it's been moving down over the last 103 days.
- SRGA ranks lowest in Stability; there it ranks in the 10th percentile.
SRGA Stock Summary
- Over the past twelve months, SRGA has reported earnings growth of 606.46%, putting it ahead of 97.24% of US stocks in our set.
- The volatility of SURGALIGN HOLDINGS INC's share price is greater than that of 99.4% US stocks with at least 200 days of trading history.
- SURGALIGN HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -66.13%, greater than the shareholder yield of only 7.19% of stocks in our set.
- Stocks that are quantitatively similar to SRGA, based on their financial statements, market capitalization, and price volatility, are XRX, TG, HAS, CBT, and EHTH.
- SRGA's SEC filings can be seen here. And to visit SURGALIGN HOLDINGS INC's official web site, go to www.rtix.com.
SRGA Valuation Summary
- SRGA's EV/EBIT ratio is -0.1; this is 100.9% lower than that of the median Healthcare stock.
- Over the past 243 months, SRGA's EV/EBIT ratio has gone up 5.6.
Below are key valuation metrics over time for SRGA.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SRGA | 2022-08-23 | 0.3 | 1.4 | -0.5 | -0.1 |
| SRGA | 2022-08-22 | 0.3 | 1.4 | -0.5 | -0.2 |
| SRGA | 2022-08-19 | 0.3 | 1.4 | -0.5 | -0.2 |
| SRGA | 2022-08-18 | 0.4 | 1.4 | -0.5 | -0.2 |
| SRGA | 2022-08-17 | 0.4 | 1.4 | -0.5 | -0.2 |
| SRGA | 2022-08-16 | 0.4 | 1.4 | -0.5 | -0.2 |
SRGA Growth Metrics
- The 4 year price growth rate now stands at 1.79%.
- Its year over year cash and equivalents growth rate is now at -29.93%.
- Its 2 year net cashflow from operations growth rate is now at -542.56%.
The table below shows SRGA's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-06-30 | 83.603 | -38.054 | -58.929 |
| 2022-03-31 | 87.814 | -56.404 | -69.433 |
| 2021-12-31 | 90.5 | -51.792 | -84.651 |
| 2021-09-30 | 94.857 | -56.98 | -139.329 |
| 2021-06-30 | 102.238 | -119.596 | -8.739 |
| 2021-03-31 | 131.629 | -109.08 | -31.111 |
SRGA's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SRGA has a Quality Grade of C, ranking ahead of 26.03% of graded US stocks.
- SRGA's asset turnover comes in at 0.676 -- ranking 55th of 186 Medical Equipment stocks.
- AHPI, HSDT, and RMD are the stocks whose asset turnover ratios are most correlated with SRGA.
The table below shows SRGA's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.676 | 0.618 | -0.273 |
| 2021-03-31 | 0.686 | 0.522 | -0.460 |
| 2020-12-31 | 0.420 | 0.568 | -0.362 |
| 2020-09-30 | 0.794 | 0.536 | -0.710 |
| 2020-06-30 | 0.707 | 0.535 | -0.912 |
| 2020-03-31 | 0.658 | 0.556 | -0.604 |
SRGA Price Target
For more insight on analysts targets of SRGA, see our SRGA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $3.36 | Average Broker Recommendation | 1.43 (Moderate Buy) |
SRGA Stock Price Chart Interactive Chart >
SRGA Price/Volume Stats
| Current price | $4.08 | 52-week high | $44.40 |
| Prev. close | $4.04 | 52-week low | $2.95 |
| Day low | $3.93 | Volume | 1,401 |
| Day high | $4.08 | Avg. volume | 103,972 |
| 50-day MA | $3.84 | Dividend yield | N/A |
| 200-day MA | $10.56 | Market Cap | 27.53M |
Surgalign Holdings, Inc. (SRGA) Company Bio
Surgalign Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides medical technology solutions with focus on spine surgery and elevating clinical outcomes. Surgalign Holdings serves customers worldwide.
Latest SRGA News From Around the Web
Below are the latest news stories about SURGALIGN HOLDINGS INC that investors may wish to consider to help them evaluate SRGA as an investment opportunity.
Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company’s New Flagship Posterior Fixation PlatformDEERFIELD, Ill., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced FDA 510(k) clearance of the CorteraTM Spinal Fixation System. This new flagship product from Surgalign is a key piece to the foundational portfolio designed to drive the Company’s future growth over the next 10 years and to enable market share gains in the estimated $2. |
Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc.Parties enter into new sole-source supply relationship, extended for two yearsDEERFIELD, Ill., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that effective August 5, 2022, the Company entered into a global settlement agreement with Pioneer Surgical Technology, Inc. d/b/a Resolve Surgical Technologies and RTI Surgical, Inc. (togethe |
Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance RangeDEERFIELD, Ill., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 second quarter ended June 30, 2022. 2022 Second Quarter Key Highlights and Subsequent Events: First successful surgical procedures utilizing the HOLO Portal™ Surgical Guidance System in Indiana and further expansion in Ohio with more site |
Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate SecretaryDEERFIELD, Ill., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the appointment of Paolo Amoruso as its new General Counsel and Corporate Secretary, effective August 1, 2022. He previously served as Interim General Counsel of Surgalign, having joined the Company in April 2022. Commenting on today’s appointment, Terry Rich, President |
Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019DEERFIELD, Ill., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) on August 3, 2022, concluding and resolving in its entirety the previously disclosed SEC investigation relating to activities that occurred between 2015 and 2019 by RTI Surgical Holdings, Inc., and RTI Surgical, Inc. and the prior management. As reflected in the SEC’s Order, those activities included pulling sales forward from f |
SRGA Price Returns
| 1-mo | -32.00% |
| 3-mo | -11.30% |
| 6-mo | -57.50% |
| 1-year | -90.62% |
| 3-year | -96.08% |
| 5-year | -96.94% |
| YTD | -81.02% |
| 2021 | -67.29% |
| 2020 | -20.07% |
| 2019 | -25.95% |
| 2018 | -9.76% |
| 2017 | 26.15% |
Loading social stream, please wait...